Tag Archives: pharmaceutical funding
L’intelligence artificielle du point de vue de la santé globale
Vincent Couture et Jean-Christophe Bélisle-Pipon explorent les nouvelles menaces existentielles qu’engendre l’intelligence artificielle restreinte et générale pour la santé mondiale et proposent des stratégies pour s’y attaquer.
Mind the Ethical Gap in AI-Powered Drug Discovery
Dessislava Fessenko shows that while artificial intelligence might revolutionize drug development, its use comes with risks and potential ethical implications. Iterative ethics oversight from the get-go is needed to address the looming concerns.
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Conflicts of Interest: The case of Diclectin
Naila Ramji advocates for the importance of clinical trial transparency.
Just Price for Drugs: The eleventh hour
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Impact Ethics 